INSIGHTS ON LIQUID DOSE MANUFACTURING
-
From Complexity To Confidence In Prefillable Syringe Transfer
Discover how aligning packaging strategy with technology transfer requirements can accelerate timelines, control costs, and support successful injectable drug product manufacturing.
-
Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
Unlock A Faster, More Efficient Route To Commercialization
Streamline commercialization with a variable-dose, disposable pen injector platform. Ideal for GLP-1 therapies, biosimilars, and generics, it combines intuitive patient handling with market entry.
-
Navigating Sterile Injectable CMO Selection: A Technical And Quality Assessment
Learn how to carry out an effective technical and quality assessment and what specific criteria to prioritize when selecting a sterile injectable CMO partner.
-
Mechanical Engineering Design Process For Combination Products7/17/2026
Mechanical engineering for combination drug-delivery devices demands more than good design — it requires data-driven risk management from specs through simulation. Learn how a structured phase approach ensures global manufacturing readiness.
-
CAR-T Cell Therapy For Cancer: The Patient's In The Process7/21/2026
Autologous cell therapies require absolute process repeatability. Learn how automated cryovial filling protects cell viability and eliminates manual variability.
-
5 Ways Pre-Filled Syringes Contribute To Better Patient Outcomes5/23/2025
In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.
-
Meet Regulation Requirements With RTU Vials And Cartridges10/9/2025
Sterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.
-
Navigating Large-Volume Subcutaneous Biologic Injections8/12/2026
Large-volume subcutaneous delivery is bringing biologic treatments closer to patients. Learn how advances in dosing and device technology are shaping care.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
ProSys S06428 Containment and Sampling Technology is a single-chamber closed-barrier system providing protection from cross-contamination between a process and the surrounding laboratory. The Isolator is rated ISO5. (International Standards Organization) (for particle count) environment in operation. An integration with a bio-decontamination system allows parametric surface bio-decontamination and their ventilation systems, prior and after processes.
-
2021 Vanrx (Cytiva) SA25 Aseptic Filling Workcell. The SA25 is a gloveless robotic isolator for aseptic fill/finish of nested vials, syringes, and cartridges. Fills 0.2–50 mL with format changeover in approximately 45 minutes. No glove ports; all filling and stoppering occurs robotically inside the isolator. GMP ready July 2022, GMP inactivation May 16, 2025. Last production 2023, four batches total. Serial# PSV00051. Built in British Columbia, Canada. Currently located in Songdo, Incheon, South Korea.
-
Implement pharma-grade liquid handling tools and tubing management systems to enforce 6S standards, reduce contamination risk, and improve cleanroom workflow efficiency.
-
Open RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved by a barrier (oRABS housing with gloves) between the operator and the product.
-
The Aseptic Filling Isolator is a custom-designed cGMP Class A/ISO 5 isolator system specifically designed for batch scale pharmaceutical production of injectable products for pre-clinical and clinical trial studies.